Helping You Build Wealth With Honest Research
Since 1996. Try Now


Invalid Username / Password
Invalid Captcha
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Sensex, Nifty Trade Higher; Sun Pharma, Dr Reddy's Lab & Tata Consumer Top Gainers
Thu, 14 Jul 10:30 am

Sensex, Nifty Trade Higher; Sun Pharma, Dr Reddys Lab & Tata Consumer Top Gainers

Major stocks in the Asian share markets traded mixed today following moderate losses on Wall Street after fresh data indicated inflation in the United States remained at a high level.

The Nikkei rose by 0.7% while the Hang Seng gained 0.2%. The Shanghai Composite is down 0.1%.

US stocks closed modestly lower on Wednesday after investors digested hotter-than-expected US inflation data, which fueled fears that the Federal Reserve could raise key interest rates by as much as 100 basis points later this month.

The Dow Jones was down 0.7% while the tech heavy Nasdaq was lower by 0.2%.

Back home, Indian share markets are trading on a firm note.

Benchmark indices opened on a flat note tracking the trend on SGX Nifty but extended gains as the session progressed.

At present, the BSE Sensex is trading higher by 267 points. Meanwhile, the NSE Nifty is trading higher by 77 points.

M&M and Titan are among the top gainers today.

TCS and NTPC are among the top losers today.

Bharti Airtel share price is falling as the Adani group has announced its foray into the telecom sector.

Broader markets are trading on a positive note. The BSE Mid Cap index is up by 0.3% while the BSE Small Cap index is trading higher by 0.3%.

--- Advertisement ---
Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Small Cap Trend Alert

Over the past 5 years the Small Cap Index

has Surged by over 200%

Our Head of Small Cap Research has a plan to play this trend

I Want the Details
Details of our SEBI Research Analyst registration are mentioned on our website -

Sectoral indices are trading on a positive note with the exception of power and utilities sectors. Stocks in the health care and finance witness most of the buying.

IT stocks, which were falling for the past couple of days, bucked the trend and are up today.

Shares of Siemens and Voltamp Transformers hit their 52-week highs.

Since you're interested in high flying stocks, check out our guide on how to pick the best multibagger stocks in 2022.

In the commodity markets, gold prices are falling. Today, prices are down by Rs 128, trading at Rs 50,802 per 10 grams.

Note that gold prices have fallen and have taken quite a knock in recent weeks.

Meanwhile, silver prices are trading lower at Rs 56,896 per kg. Silver price too has fallen a lot in recent days.

Cryptos and the speculations around them has left everyone confused. On one hand the government does not identify as a legal tender and on the other hand the returns were just too good to resist.

One of the very prevalent views on crypto is that it is just a scam. With no underlying value and no legal identification, it is believed that crypto is nothing but a bubble that will burst anytime.

Especially with the recent OneCoin scam we are forced to ask, is crypto only a scam? Nithin Eapen explains in the below video about the crypto queen and other frauds in crypto markets.

In news from finance sector HDFC plans to raise funds.

Mortgage major HDFC will launch an issue of bonds on a private placement basis on Friday to raise up to Rs 50 bn. The secured redeemable non-convertible debentures (NCDs) will bear interest rate at 7.77%, payable annually and has a tenor of 4 years 11 months and 10 days.

Discover: How to Grow Your Wealth in a Stress-Free Way

The issue size is of Rs 25 bn with an option to retain oversubscription of Rs 25 bn. The issue opens on 15 July 2022 and closes on the same day. Axis Bank is the arranger of the proposed bonds issue.

Note that the news of HDFC and HDFC Bank merger seems to have negatively impacted the share price of both companies.

HDFC Bank share price has seen a sharp decline in the share price after the merger news.


However, the fall seems temporary. Once investors see the synergies of the merger the share price may start rising again.

Further in news from the FMCG sector, Dabur has made big investments.

Dabur India through its subsidiaries has acquired the entire stake in Bangladesh-based Asian Consumer Care from its joint venture partner Advanced Chemical Industries for about Rs 510 m.

Dabur held 76 %stake in the firm before acquisition through its subsidiary Dabur International, while the remaining 24%was held by Advanced Chemical Industries.

--- Advertisement ---
Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Could the Bears Strike During Election Season?

Discover how this Safe Stock Strategy Could Protect Your Wealth & Potentially Lead to Big Long Term Gains

Full details here
Details of our SEBI Research Analyst registration are mentioned on our website -

Further in news from IT sector, Infosys also has some investment news.

On Wednesday, Infosys signed a definitive agreement to acquire Denmark-based BASE life science, a leading technology and consulting firm in the life sciences industry, for up to € 110 million.

The acquisition is expected to close during the second quarter of FY23.

The life sciences vertical contributes 6.6% to Infosys' total revenues and it grew 16.2% year-on-year in constant currency for the March quarter.

Headquartered in Denmark, BASE has about 200 multidisciplinary industry experts across Denmark, Switzerland, UK, Germany, France, Italy, and a nearshore technology hub in Spain.

Together with Infosys, BASE is expected to further expand its portfolio of expertise into Consumer Health, Animal Health, MedTech and Genomics segments. BASE collaborates with leading software technology providers in the life sciences industry such as Veeva, IQVIA and Salesforce.

Continuing news from the IT sector, Mindtree posted its Q1 results yesterday.

On Wednesday Mindtree reported net profit of Rs 4,720 m, up 37% year-on-year, in the June quarter. But the company's PAT was down 0.3% sequentially.

Revenue for the quarter grew 36.2% y-o-y at Rs 31,210 m for the first quarter of fiscal of 2023. Revenue was up 7.7% on a quarter-on-quarter basis. The company signed a total contract value of $570 million during the quarter, the highest ever for the company.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sensex, Nifty Trade Higher; Sun Pharma, Dr Reddy's Lab & Tata Consumer Top Gainers". Click here!